Lung | Stomach, Phase I-II
A Phase 1b, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 (pINN) Sotorasib Monotherapy and in Combination With Other Anti-cancer Therapies in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Volunteers
Health Professionals
What is the purpose of this trial?
To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult subjects with KRAS p.G12C mutant advanced solid tumors.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Anne Chiang, MD, PhD
- Emily Duffield, APRN
- Frederick Wilson, MD, PhD
- Jeremy Kortmansky, MD
- Jill Lacy, MD
- John Glendening
- Laura Van Metre Baum, MD, MPH
- Marianne Davies, NP, DNP, MSN, BSN
- Michael Cecchini, MD
- Ninani Kombo, MD
- Pamela L. Kunz, MD
- Roy S. Herbst, MD, PhD
- Scott Gettinger, MD
- So Yeon Kim, MD
- Stacey Stein, MD
- Teresa White
- Vanna Dest
- Last Updated02/22/2024
- Study HIC#2000026544